Pharma in 2014: Deals worth billions and fines worth millions
It's been a year of bitter medicine for Indian pharma companies with fines worth millions of dollars imposed by various foreign regulators, even as they stitched together deals worth billions of dollars, including the high profile Sun-Ranbaxy merger.
Dec 26, 2014, 11:27 AM IST